STAT Plus: After backlash, Teva will resume supplies of a critical children’s cancer medicine
Good for . But the chaos described in the article seems avoidable. & pharma, treat this as a sentinel event, learn the lessons it teaches, and design a better system.
After backlash, Teva will resume supplies of a critical children’s cancer medicine via
After backlash, will resume supplies of a critical children’s #cancer medicine #vincristine, by via #DrugShortages